Global Tyrosine Kinase Inhibitors Market 2024-2028

The tyrosine kinase inhibitors market is forecasted to grow by USD 24.22 bn during 2023-2028, accelerating at a CAGR of 8.42% during the forecast period. The report on the tyrosine kinase inhibitors market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by high target affinity and specificity of tyrosine kinase inhibitors, rising availability of patient assistance programs, and increasing prevalence of cancer worldwide.

Market Scope
Base Year	2024
End Year	2028
Series Year	2024-2028
Growth Momentum	Accelerate
YOY 2024	7.96%
CAGR	8.42%
Incremental Value	$24.22bn

Technavio's tyrosine kinase inhibitors market is segmented as below:

By Distribution Channel

Offline
Online

By Product

RTKIs
nRTKIs

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the strategic alliances among market vendors as one of the prime reasons driving the tyrosine kinase inhibitors market growth during the next few years. Also, expansion of research areas in tyrosine kinase inhibitor therapeutics and increasing launches of biosimilars will lead to sizable demand in the market.

The report on the tyrosine kinase inhibitors market covers the following areas:

Tyrosine kinase inhibitors market sizing
Tyrosine kinase inhibitors market forecast
Tyrosine kinase inhibitors market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading tyrosine kinase inhibitors market vendors that include AbbVie Inc., Amgen Inc., AstraZeneca Plc, Bayer AG, Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., Danaher Corp., Deciphera Pharmaceuticals Inc., Eisai Co. Ltd., Eli Lilly and Co., Exelixis Inc., F. Hoffmann La Roche Ltd., Johnson and Johnson, Merck KGaA, Novartis AG, Pfizer Inc., Puma Biotechnology Inc., Rigel Pharmaceuticals Inc., Takeda Pharmaceutical Co. Ltd., and Tokyo Chemical Industry Co. Ltd.. Also, the tyrosine kinase inhibitors market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR74141

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 06: Executive Summary - Chart on Market Segmentation by Product
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global tyrosine kinase inhibitors market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global tyrosine kinase inhibitors market 2018 - 2022 ($ billion)
4.2 Distribution channel Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Distribution channel Segment 2018 - 2022 ($ billion)
4.3 Product Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - Product Segment 2018 - 2022 ($ billion)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)

5 Five Forces Analysis

5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Distribution Channel

6.1 Market segments
Exhibit 30: Chart on Distribution Channel - Market share 2023-2028 (%)
Exhibit 31: Data Table on Distribution Channel - Market share 2023-2028 (%)
6.2 Comparison by Distribution Channel
Exhibit 32: Chart on Comparison by Distribution Channel
Exhibit 33: Data Table on Comparison by Distribution Channel
6.3 Offline - Market size and forecast 2023-2028
Exhibit 34: Chart on Offline - Market size and forecast 2023-2028 ($ billion)
Exhibit 35: Data Table on Offline - Market size and forecast 2023-2028 ($ billion)
Exhibit 36: Chart on Offline - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Offline - Year-over-year growth 2023-2028 (%)
6.4 Online - Market size and forecast 2023-2028
Exhibit 38: Chart on Online - Market size and forecast 2023-2028 ($ billion)
Exhibit 39: Data Table on Online - Market size and forecast 2023-2028 ($ billion)
Exhibit 40: Chart on Online - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Online - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by Distribution Channel
Exhibit 42: Market opportunity by Distribution Channel ($ billion)
Exhibit 43: Data Table on Market opportunity by Distribution Channel ($ billion)

7 Market Segmentation by Product

7.1 Market segments
Exhibit 44: Chart on Product - Market share 2023-2028 (%)
Exhibit 45: Data Table on Product - Market share 2023-2028 (%)
7.2 Comparison by Product
Exhibit 46: Chart on Comparison by Product
Exhibit 47: Data Table on Comparison by Product
7.3 RTKIs - Market size and forecast 2023-2028
Exhibit 48: Chart on RTKIs - Market size and forecast 2023-2028 ($ billion)
Exhibit 49: Data Table on RTKIs - Market size and forecast 2023-2028 ($ billion)
Exhibit 50: Chart on RTKIs - Year-over-year growth 2023-2028 (%)
Exhibit 51: Data Table on RTKIs - Year-over-year growth 2023-2028 (%)
7.4 nRTKIs - Market size and forecast 2023-2028
Exhibit 52: Chart on nRTKIs - Market size and forecast 2023-2028 ($ billion)
Exhibit 53: Data Table on nRTKIs - Market size and forecast 2023-2028 ($ billion)
Exhibit 54: Chart on nRTKIs - Year-over-year growth 2023-2028 (%)
Exhibit 55: Data Table on nRTKIs - Year-over-year growth 2023-2028 (%)
7.5 Market opportunity by Product
Exhibit 56: Market opportunity by Product ($ billion)
Exhibit 57: Data Table on Market opportunity by Product ($ billion)

8 Customer Landscape

8.1 Customer landscape overview
Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
Exhibit 59: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 60: Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Exhibit 61: Chart on Geographic comparison
Exhibit 62: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 63: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 64: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 65: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 66: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 67: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 68: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 69: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 70: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 71: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 72: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 73: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 74: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 79: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 80: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 81: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Germany - Market size and forecast 2023-2028
Exhibit 83: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 84: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 85: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.9 UK - Market size and forecast 2023-2028
Exhibit 87: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibit 88: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibit 89: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on UK - Year-over-year growth 2023-2028 (%)
9.10 China - Market size and forecast 2023-2028
Exhibit 91: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibit 92: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibit 93: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on China - Year-over-year growth 2023-2028 (%)
9.11 Canada - Market size and forecast 2023-2028
Exhibit 95: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibit 96: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibit 97: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 99: Market opportunity By Geographical Landscape ($ billion)
Exhibit 100: Data Tables on Market opportunity By Geographical Landscape ($ billion)

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 101: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 103: Overview on factors of disruption
11.4 Industry risks
Exhibit 104: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
Exhibit 105: Vendors covered
12.2 Market positioning of vendors
Exhibit 106: Matrix on vendor position and classification
12.3 AbbVie Inc.
Exhibit 107: AbbVie Inc. - Overview
Exhibit 108: AbbVie Inc. - Product / Service
Exhibit 109: AbbVie Inc. - Key news
Exhibit 110: AbbVie Inc. - Key offerings
12.4 Amgen Inc.
Exhibit 111: Amgen Inc. - Overview
Exhibit 112: Amgen Inc. - Product / Service
Exhibit 113: Amgen Inc. - Key offerings
12.5 AstraZeneca Plc
Exhibit 114: AstraZeneca Plc - Overview
Exhibit 115: AstraZeneca Plc - Product / Service
Exhibit 116: AstraZeneca Plc - Key news
Exhibit 117: AstraZeneca Plc - Key offerings
12.6 Bayer AG
Exhibit 118: Bayer AG - Overview
Exhibit 119: Bayer AG - Business segments
Exhibit 120: Bayer AG - Key news
Exhibit 121: Bayer AG - Key offerings
Exhibit 122: Bayer AG - Segment focus
12.7 Boehringer Ingelheim International GmbH
Exhibit 123: Boehringer Ingelheim International GmbH - Overview
Exhibit 124: Boehringer Ingelheim International GmbH - Business segments
Exhibit 125: Boehringer Ingelheim International GmbH - Key news
Exhibit 126: Boehringer Ingelheim International GmbH - Key offerings
Exhibit 127: Boehringer Ingelheim International GmbH - Segment focus
12.8 Bristol Myers Squibb Co.
Exhibit 128: Bristol Myers Squibb Co. - Overview
Exhibit 129: Bristol Myers Squibb Co. - Product / Service
Exhibit 130: Bristol Myers Squibb Co. - Key news
Exhibit 131: Bristol Myers Squibb Co. - Key offerings
12.9 Danaher Corp.
Exhibit 132: Danaher Corp. - Overview
Exhibit 133: Danaher Corp. - Business segments
Exhibit 134: Danaher Corp. - Key news
Exhibit 135: Danaher Corp. - Key offerings
Exhibit 136: Danaher Corp. - Segment focus
12.10 Eisai Co. Ltd.
Exhibit 137: Eisai Co. Ltd. - Overview
Exhibit 138: Eisai Co. Ltd. - Business segments
Exhibit 139: Eisai Co. Ltd. - Key offerings
Exhibit 140: Eisai Co. Ltd. - Segment focus
12.11 Eli Lilly and Co.
Exhibit 141: Eli Lilly and Co. - Overview
Exhibit 142: Eli Lilly and Co. - Product / Service
Exhibit 143: Eli Lilly and Co. - Key news
Exhibit 144: Eli Lilly and Co. - Key offerings
12.12 Exelixis Inc.
Exhibit 145: Exelixis Inc. - Overview
Exhibit 146: Exelixis Inc. - Product / Service
Exhibit 147: Exelixis Inc. - Key offerings
12.13 F. Hoffmann La Roche Ltd.
Exhibit 148: F. Hoffmann La Roche Ltd. - Overview
Exhibit 149: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 150: F. Hoffmann La Roche Ltd. - Key news
Exhibit 151: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 152: F. Hoffmann La Roche Ltd. - Segment focus
12.14 Johnson and Johnson
Exhibit 153: Johnson and Johnson - Overview
Exhibit 154: Johnson and Johnson - Business segments
Exhibit 155: Johnson and Johnson - Key news
Exhibit 156: Johnson and Johnson - Key offerings
Exhibit 157: Johnson and Johnson - Segment focus
12.15 Novartis AG
Exhibit 158: Novartis AG - Overview
Exhibit 159: Novartis AG - Business segments
Exhibit 160: Novartis AG - Key offerings
Exhibit 161: Novartis AG - Segment focus
12.16 Pfizer Inc.
Exhibit 162: Pfizer Inc. - Overview
Exhibit 163: Pfizer Inc. - Product / Service
Exhibit 164: Pfizer Inc. - Key news
Exhibit 165: Pfizer Inc. - Key offerings
12.17 Takeda Pharmaceutical Co. Ltd.
Exhibit 166: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibit 167: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibit 168: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibit 169: Takeda Pharmaceutical Co. Ltd. - Key offerings

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 170: Inclusions checklist
Exhibit 171: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 172: Currency conversion rates for US$
13.4 Research methodology
Exhibit 173: Research methodology
Exhibit 174: Validation techniques employed for market sizing
Exhibit 175: Information sources
13.5 List of abbreviations
Exhibit 176: List of abbreviations